HealthcareMid capRs 9,406 crRs 1.5 cr traded a dayThin: a ₹2 lakh order is 1.3% of a normal day
Close on 10 September 2026
4,089.60
+0.99%
52-week range9% of the way up
3,999.505,048.00
Market cap
9,406 cr
P/E (TTM)
38.0×
industry 45×
EPS (TTM)
107.57
Revenue YoY
+43.4%
Q1 FY27
Profit YoY
+137.2%
Net margin
29.2%
+11.5pt vs a year ago
1 month
-8.7%
Below 52w high
23.4%
RSI (14)
36
Daily swing
2.6%
average true range
Volume
1.1×
vs 20-day average
Traded
Rs 2 cr
median day
Close200-day averageMaterial filing
260 sessions · hover for the filing behind a move
Key metrics
each ranked against every stock scanned tonight
Above the 200-day average
Below the median
-8.4%
One-year return
Below the median
-19.9%
Return on capital employed
Top of the universe
96.6%
Debt to equity
Top of the universe
0.00×
Profitable quarters, last four
of the last four reported
4 of 4
Cash conversion
cash from operations against reported profit
59%
Revenue growth, year on year
latest reported quarter
+43.4%
Below the 52-week high
from the highest close of the year
-19.0%
1 week
−2.75%
1 month
−8.68%
3 months
−13.36%
6 months
−4.44%
1 year
−19.87%
The read
written from the numbers on this page
The evidence is mixed5 supporting, 4 against, 0 worth knowing
Supporting
matches more cash than borrowings, which has beaten the market by +1.47 points over 20 sessions across 6,919 past signals
7 of the scans it matches have a positive measured record
3 independent kinds of evidence agree today, which is uncommon
revenue grew 43% year on year in the quarter ending 30 June 2026
net margin has widened from 26.0% to 29.2% across four quarters
Against
trading 8% below its 200-day average
at 9% of its 52-week range — nearly everyone who bought in the past year is underwater
down 20% over twelve months
1 of the scans it matches has historically underperformed the market
Worth knowing
nothing the data supports either way
What would change this read: a close back above 4,467, its 200-day average.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
What is working, what is not
from the filings and from the price, with the figure behind every line
Working3
Net profit rose 52.9% year on year, from Rs 45 cr to Rs 69 cr.
+52.9%Rs 45 crRs 69 cr
Revenue rose 47.4% year on year, from Rs 160 cr to Rs 236 cr.
+47.4%Rs 160 crRs 236 cr
Net margin improved from 28.1% to 29.2%.
28.1%29.2%
Needs watching5
Trading 8.4% below its 200-day average.
-8.4%
Only 2.3% above its 52-week low.
+2.3%
Down 19.9% over the past year.
-19.9%
A warning rule fires on it tonight: near a 52-week low.
Near a 52-week low
Only Rs 1.5 crore changes hands on a median day. A large order moves this price by itself.
Rs 1.5 cr
Every figure here is computed — from the company’s own filings, or from its own closing prices. Wording of 3 of these 3 filing lines was drafted by a language model, which is given the figures and may not introduce another — any sentence containing a number that did not come from the filings is discarded before it reaches this page.
How it has performed
price return over each window, beside the median NSE stock over the same days
What the scans say today
8 of 47 matched on 10 Sep
SANOFICONR matches 8 of the 47 scans today, across 3 different kinds of evidence. Three or more independent families agreeing is uncommon — it is the same test the shortlist on every page uses.
Return on capital uses profit before tax over equity plus borrowings. The textbook version adds finance costs back; those are not tagged reliably in quarterly filings, so this understates the ratio for a heavily borrowed company rather than flattering it. Balance sheets are filed half-yearly, so these can be up to six months behind the profit figures above.
Valuation against its own history
142 sessions since 25 February 2026
39×
median 48×
58×
now 38×
SANOFICONR trades at 38× trailing earnings, below its median of 48× over this window — 21% less expensive than usual. The band runs from the 5th to the 95th percentile, so single-day spikes do not set the edges.
This window is short by the standards of valuation history — it begins where four quarters of filed earnings first exist. A stock can look cheap against two years and expensive against ten.
The business
from the company’s filed results
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.
Going for it
revenue grew 43% against the same quarter a year earlier
profit rose 137% year on year
revenue rose in 3 of the last 4 quarters
Going against it
net margin narrowed from 29.6% to 29.2%
Quarter-by-quarter numbers, as filed
Quarter
Revenue
Profit before tax
Net profit
EPS
Net margin
Q1 FY27
30 Jun · standalone
236
92
69
29.87
29.2%
Q4 FY26
31 Mar · standalone
229
91
68
29.44
29.6%
Q3 FY26
31 Dec · standalone
251
90
66
28.87
26.5%
Q3 FY25
31 Dec · standalone
171
63
44
19.25
26.0%
Q2 FY25
30 Sep · standalone
160
61
45
19.54
28.1%
Q1 FY25
30 Jun · standalone
164
39
29
12.58
17.6%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average-7.6%
Versus 200-day average-8.4%
Below 52-week high-19.0%
Above 52-week low+2.3%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)36.1
Higher closes in last 51 of 5
Six-month return−4.44%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.
Typical daily swing (ATR)2.59%
Volume versus 20-day1.1x
Median daily turnoverRs 1.5 cr
Peers
Healthcare · 68 classified companies
SANOFICONR trades at 38.0× trailing earnings against an industry median of 44.7× across 65 other classified companies in its industry — cheaper than them, by 15%. A multiple is a statement about expectations, not about quality: cheap usually means the market expects less, and it is often right.
largest twelve by market capitalisation. Market cap and P/E need filed financials, so blanks are companies whose filings have not been read yet
Recent sessions
what this stock has matched since the engine went live
This is the live record, not the backtest — the scans this stock actually appeared in on each stored session. A name that keeps reappearing is in a persistent condition; a one-day appearance usually is not.